Thiȿ month, Northern Leaf wiIl set up the service at its 100, 000 square ƒoot EU-GMP faciIity in Șt Lawrence, Jersey, wⱨere it įs estimated to export medicaI cannaƀis to 90 % of the island.
After a 25 % increase in the company’s production capacity last year, the association gives 3R Biotech a German center for advanced cell culture and allows Northern Leaf to store and reproduce plant biology on page.
According to Robert Allen, CEO of 3R Biotech,” German physician cannabis producers have long supplied plant health services piecemeal- testing from one provider, propagation from another, remediation from a second, and qualified clean genetics from somewhere else entirely. “
“3R Europe makes that change,” bringing the entire plant health services bundle together for the first time in Europe.
Allen added that tissue culture “provides a way to standardize plant material, reduce disease risk at the source, and assure consistent performance across production” and that the cost of inconsistency increases as cultivation costs rise.
As Northern Leaf weights bulk cannabis flower exports to regulated European markets, including Germany, where Northern Leaf supplied 3, 590 kilograms of flower in 2025, Steven Tan, Chief Executive Officer, said the hospital would give the business” stronger power over plant health, genetic dignity, and THC regularity. “
Tan described tissue culture as” the foundation that provides everything from disease-free propagation to advanced breeding methods and new cultivar development,” and that the technology might eventually be applied to other Jersey crops, such as the Jersey Royal potato.
Addįtionally, the facilitყ establishes a regional scientific position. After training with 3R Biotech in Washington, Carolina Hayes, a Jersey-born biomedical science graduate, has joined Northern Leaf as a Tissue Culture Associate.
Over the past two years, Northern Leaf’s capacity increased by fivefold, bringing in a fivefold increase in revenue from 25 % to 75 % of the St Lawrence site’s total output.
